Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Transient ischaemic attack? 820 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 820 reports of Transient ischaemic attack have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.6% of all adverse event reports for RIVAROXABAN.

820
Reports of Transient ischaemic attack with RIVAROXABAN
0.6%
of all RIVAROXABAN reports
40
Deaths
450
Hospitalizations

How Dangerous Is Transient ischaemic attack From RIVAROXABAN?

Of the 820 reports, 40 (4.9%) resulted in death, 450 (54.9%) required hospitalization, and 36 (4.4%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 820 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454) SIMVASTATIN (415)

Which RIVAROXABAN Alternatives Have Lower Transient ischaemic attack Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack RIVAROXABAN Demographics